JP2019517590A5 - - Google Patents

Download PDF

Info

Publication number
JP2019517590A5
JP2019517590A5 JP2019516293A JP2019516293A JP2019517590A5 JP 2019517590 A5 JP2019517590 A5 JP 2019517590A5 JP 2019516293 A JP2019516293 A JP 2019516293A JP 2019516293 A JP2019516293 A JP 2019516293A JP 2019517590 A5 JP2019517590 A5 JP 2019517590A5
Authority
JP
Japan
Prior art keywords
active agent
composition
condition
porous
excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019516293A
Other languages
English (en)
Japanese (ja)
Other versions
JP7542309B2 (ja
JP2019517590A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/053288 external-priority patent/WO2017208209A1/en
Publication of JP2019517590A publication Critical patent/JP2019517590A/ja
Publication of JP2019517590A5 publication Critical patent/JP2019517590A5/ja
Priority to JP2022067716A priority Critical patent/JP7571078B2/ja
Application granted granted Critical
Publication of JP7542309B2 publication Critical patent/JP7542309B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019516293A 2016-06-03 2017-06-02 多孔性賦形剤を含む経鼻用医薬組成物 Active JP7542309B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022067716A JP7571078B2 (ja) 2016-06-03 2022-04-15 多孔性賦形剤を含む経鼻用医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662345369P 2016-06-03 2016-06-03
US62/345,369 2016-06-03
PCT/IB2017/053288 WO2017208209A1 (en) 2016-06-03 2017-06-02 Nasal pharmaceutical compositions with a porous excipient

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022067716A Division JP7571078B2 (ja) 2016-06-03 2022-04-15 多孔性賦形剤を含む経鼻用医薬組成物

Publications (3)

Publication Number Publication Date
JP2019517590A JP2019517590A (ja) 2019-06-24
JP2019517590A5 true JP2019517590A5 (enExample) 2020-07-16
JP7542309B2 JP7542309B2 (ja) 2024-08-30

Family

ID=59078127

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019516293A Active JP7542309B2 (ja) 2016-06-03 2017-06-02 多孔性賦形剤を含む経鼻用医薬組成物
JP2022067716A Active JP7571078B2 (ja) 2016-06-03 2022-04-15 多孔性賦形剤を含む経鼻用医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022067716A Active JP7571078B2 (ja) 2016-06-03 2022-04-15 多孔性賦形剤を含む経鼻用医薬組成物

Country Status (12)

Country Link
US (1) US11903951B2 (enExample)
EP (1) EP3463375A1 (enExample)
JP (2) JP7542309B2 (enExample)
KR (1) KR102387241B1 (enExample)
CN (1) CN109803663A (enExample)
AU (1) AU2017274649B2 (enExample)
CA (1) CA3026041A1 (enExample)
EA (1) EA201892595A1 (enExample)
MX (1) MX389588B (enExample)
SG (1) SG11201810628XA (enExample)
WO (1) WO2017208209A1 (enExample)
ZA (1) ZA201808551B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201906616VA (en) 2017-01-20 2019-08-27 M et P Pharma AG Nasal pharmaceutical compositions for reducing the risks of exposure to air pollutants
RU2020126425A (ru) 2018-01-11 2022-02-11 М Эт П Фарма Аг Лечение демиелинизирующих заболеваний
CN110573145B (zh) * 2018-01-22 2021-02-26 北京茵诺医药科技有限公司 用于靶向活化cd44分子的介孔/中空二氧化硅纳米载体递送系统、其制备方法和用途
AU2019256828A1 (en) * 2018-04-17 2020-12-03 M et P Pharma AG Compositions and methods for intranasal delivery of pregnenolone
EP3837266A1 (en) 2018-08-17 2021-06-23 Massachusetts Institute of Technology Degradable polymers of a cyclic silyl ether and uses thereof
WO2021096591A1 (en) 2019-11-15 2021-05-20 Massachusetts Institute Of Technology Functional oligomers and functional polymers including hydroxylated polymers and conjugates thereof and uses thereof
US20230028539A1 (en) * 2019-12-06 2023-01-26 Shanghai Pharmaceuticals Holding Co., Ltd. Pharmaceutical composition, complementary kit and application thereof
JP2023526098A (ja) 2020-05-18 2023-06-20 オレクソ・アクチエボラゲット 薬物送達のための新しい医薬組成物
JP2021000483A (ja) * 2020-09-15 2021-01-07 株式会社三洋物産 遊技機
JP2021000481A (ja) * 2020-09-15 2021-01-07 株式会社三洋物産 遊技機
JP2021000484A (ja) * 2020-09-15 2021-01-07 株式会社三洋物産 遊技機
CN112263546B (zh) * 2020-09-29 2021-08-10 南京大学 通过鼻腔给药的佐匹克隆混悬液纳米制剂及其制备方法
WO2022164503A1 (en) 2021-02-01 2022-08-04 Massachusetts Institute Of Technology Reprocessable compositions
CN112972428B (zh) * 2021-03-09 2022-03-08 石河子大学 两性离子聚合物膜包覆的介孔硅基药物载体及制备方法
CN113456576B (zh) * 2021-06-28 2022-09-16 华中科技大学 纳米材料用于制备鼻腔纳米制剂脑靶向递送肠道药物应用
CA3238850A1 (en) 2021-11-25 2023-06-01 Jonas Savmarker Pharmaceutical composition comprising adrenaline
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device
US20230310440A1 (en) * 2022-04-01 2023-10-05 Enalare Therapeutics Inc. Respiratory stimulant nasal formulations
CN115505052B (zh) * 2022-08-23 2023-05-23 安徽普利药业有限公司 一种β-环糊精衍生物的制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002597A (en) 1989-04-03 1991-03-26 Invent Ag Aerodynamic filter
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
DE19701912C1 (de) * 1997-01-10 1998-05-14 Jenapharm Gmbh Injizierbares Implantat
DE10064950A1 (de) 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
US7563451B2 (en) * 2003-07-22 2009-07-21 Iowa State University Research Foundation, Inc. Capped mesoporous silicates
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
EP1530965B1 (en) 2003-11-11 2006-03-08 Mattern, Udo Controlled release delivery system of sexual hormones for nasal application
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
US20070077309A1 (en) * 2005-09-30 2007-04-05 Wong Patrick S Banded controlled release nanoparticle active agent formulation dosage forms and methods
ZA200902902B (en) * 2006-10-04 2010-07-28 M & P Patent Aktinegesellschaf Controlled release delivery system for nasal application of neurotransmitters
DE602007013437D1 (enExample) 2006-10-13 2011-05-05 Philips Intellectual Property
US8258137B2 (en) * 2008-01-29 2012-09-04 Katholieke Universiteit Leuven Process for release of biologically active species from mesoporous oxide systems
WO2010039560A2 (en) * 2008-09-23 2010-04-08 Laboratory Skin Care, Inc. Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
EP2349336B1 (en) * 2008-10-28 2017-11-22 Agency For Science, Technology And Research Mesoporous material excipients for poorly aqueous soluble ingredients
US20130040922A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal 0.45% and 0.48% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
CA2835911C (en) 2011-05-13 2022-08-30 Trimel Biopharma Srl Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
KR20140045400A (ko) 2011-05-15 2014-04-16 트리멜 바이오파마 에스알엘 비내용 테스토스테론 바이오-접착제 겔 제형 및 남성의 성선기능저하증을 치료하기 위한 그의 용도
ITTO20111242A1 (it) * 2011-12-30 2013-07-01 Miso S R L Composizioni per il trattamento di patologie delle mucose
EP2911690A1 (en) * 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
US20150297733A1 (en) * 2012-11-14 2015-10-22 Trimel Biopharma Srl Controlled release topical testosterone formulations and methods
US20150290217A1 (en) * 2012-11-21 2015-10-15 Trimel Biopharma Srl Male testosterone titration methods, male intranasal testosterone bio-adhesive gel formulations and use thereof for treating hypogonadism and trt
EP3065717A1 (en) * 2013-11-04 2016-09-14 Biopharmx, Inc. Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
EP3193836A1 (en) * 2014-09-15 2017-07-26 PharmaSol GmbH Active-loaded particulate materials for topical administration
US11123391B2 (en) 2015-08-04 2021-09-21 Inqpharm Group Sdn Bhd Nasal composition
EP3347124A1 (en) 2015-09-09 2018-07-18 King Abdullah University Of Science And Technology Functionalized sio2 microspheres for extracting oil from produced water
EP3229549B1 (en) * 2016-04-08 2018-11-21 Panasonic Intellectual Property Corporation of America Procedures for grouping wearable devices with lte master ues
SG11201906616VA (en) 2017-01-20 2019-08-27 M et P Pharma AG Nasal pharmaceutical compositions for reducing the risks of exposure to air pollutants

Similar Documents

Publication Publication Date Title
JP2019517590A5 (enExample)
JP7571078B2 (ja) 多孔性賦形剤を含む経鼻用医薬組成物
JP7366178B2 (ja) 鼻腔内薬学的粉末組成物
CN102046153B (zh) 包含布立西坦的药物组合物
CN102325526B (zh) 延长释放的药物制剂
EP1803446B1 (en) Orally disintegrating tablet and method of preparation
ES2517244T3 (es) Forma farmacéutica hinchable que comprende goma gellan
CN107811980B (zh) 快速溶解固体剂型
CN1134108A (zh) 用于控释的新颗粒及含有该颗粒的药物制剂
SI9800128B (sl) Enterična zrnca fluoksetina
US20210386858A1 (en) Mucoadhesive compositions and uses thereof
CN107405300A (zh) 经皮药物投予装置
Domínguez-Delgado et al. Drug Carrier Systems Using Chitosan for Non Parenteral
CN117098533A (zh) γ-羟基丁酸衍生物的组合释放型制剂的药物动力学
CN118829647A (zh) 白介素-23受体的肽抑制剂及其药物组合物
JP2005508872A5 (enExample)
JP2021517150A (ja) 圧縮医薬剤形にて使用するための多孔質シリカ粒子
CN101669917A (zh) 一种基于“NiMS”系统的氢溴酸东莨菪碱口腔速崩微囊片
CN1921888A (zh) 盐酸坦舒洛新的口服组合物和包含该组合物的控释颗粒制剂
JP2020531543A (ja) アマンタジン組成物、その調製、および使用方法
Elmowafy et al. Polysaccharide-based platforms for nasal delivery: design, features, and perspectives
JP2001055323A (ja) 粉末状経鼻投与用組成物
KR20140003544A (ko) 약제학적 제제
Bano et al. Fast-Melt Tablets (FMTs): Revolutionizing rapid relief-an in-depth review of swift dissolve technology
CN107753446B (zh) 一种雷沙吉兰片剂及其制备方法